On ECHEMI
Home > Drugs > Chongqing Jirui Pharmaceutical Co., Ltd.
Chongqing Jirui Pharmaceutical Co., Ltd.
  • Founded in:

    2020-06-03
  • Country:

    China China
  • Address:

    Building 10, No. 1, Jiangxia Road, Nan'an District, Chongqing
  • Tax NO.:

    91500108MA60YB7X8C
  • Registered Funds:

    10 million yuan
  • Email:

Related Drugs
Cefmetazole Sodium
Name Description Content CAS NO. Registered Holders
Cefmetazole sodium

Extract from the above information

More

Extract from the above information

56796-39-5 14
Evening primrose oil lotion
The main ingredients of this product are: oral emulsion containing % evening primrose oil.
Name Description Content CAS NO. Registered Holders
Evening primrose oil

It has the effect of lowering triglycerides, cholesterol and beta-lipoprotein, and has an inhibitory effect on arteriosclerosis

More

It has the effect of lowering triglycerides, cholesterol and beta-lipoprotein, and has an inhibitory effect on arteriosclerosis

90028-66-3 2
Cefoperazone Sodium for Injection
The main ingredient of this product is cefoperazone sodium.
Name Description Content CAS NO. Registered Holders
Cefoperazone sodium

It achieves bactericidal effect by inhibiting the synthesis of bacterial cell wall. It has bactericidal effect on a wide range of common clinical bacteria and can resist hydrolysis by a variety of beta-lactamases. Bacteria sensitive to this product include Gram-positive bacteria, Gram-negative bacteria, anaerobic bacteria, etc.

More

It achieves bactericidal effect by inhibiting the synthesis of bacterial cell wall. It has bactericidal effect on a wide range of common clinical bacteria and can resist hydrolysis by a variety of beta-lactamases. Bacteria sensitive to this product include Gram-positive bacteria, Gram-negative bacteria, anaerobic bacteria, etc.

62893-20-3 23
Cefoperazone Sodium for Injection
The main ingredient of this product is cefoperazone sodium.
Name Description Content CAS NO. Registered Holders
Cefoperazone sodium

It achieves bactericidal effect by inhibiting the synthesis of bacterial cell wall. It has bactericidal effect on a wide range of common clinical bacteria and can resist hydrolysis by multiple beta-lactamases. Bacteria sensitive to this product include Gram-positive bacteria: Staphylococcus aureus (including strains that produce and do not produce penicillinase), Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus pyogenes, and Streptococcus agalactiae. Gram-negative bacteria: Escherichia coli, Klebsiella, Enterobacter, Citrobacter, Haemophilus influenzae (including strains that produce and do not produce beta-lactamase), Proteus mirabilis, Proteus vulgaris, Morganella morganii, Providencia, Serratia, Salmonella, Shigella. Pseudomonas aeruginosa and some other Pseudomonas, some strains of calcoacetic Acinetobacter. Neisseria gonorrhoeae (including strains that produce and do not produce penicillinase), Neisseria meningitidis, Bordetella pertussis. Anaerobic bacteria: Peptococcus, Peptostreptococcus, Veillonella, Clostridium, Eubacterium, Lactobacillus, Fusobacterium, various strains of Bacillus fragilis, and other Bacteroides.

More

It achieves bactericidal effect by inhibiting the synthesis of bacterial cell wall. It has bactericidal effect on a wide range of common clinical bacteria and can resist hydrolysis by multiple beta-lactamases. Bacteria sensitive to this product include Gram-positive bacteria: Staphylococcus aureus (including strains that produce and do not produce penicillinase), Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus pyogenes, and Streptococcus agalactiae. Gram-negative bacteria: Escherichia coli, Klebsiella, Enterobacter, Citrobacter, Haemophilus influenzae (including strains that produce and do not produce beta-lactamase), Proteus mirabilis, Proteus vulgaris, Morganella morganii, Providencia, Serratia, Salmonella, Shigella. Pseudomonas aeruginosa and some other Pseudomonas, some strains of calcoacetic Acinetobacter. Neisseria gonorrhoeae (including strains that produce and do not produce penicillinase), Neisseria meningitidis, Bordetella pertussis. Anaerobic bacteria: Peptococcus, Peptostreptococcus, Veillonella, Clostridium, Eubacterium, Lactobacillus, Fusobacterium, various strains of Bacillus fragilis, and other Bacteroides.

62893-20-3 23
Cefoperazone Sodium for Injection
The main ingredient of this product is cefoperazone sodium.
Name Description Content CAS NO. Registered Holders
Cefoperazone sodium

It achieves bactericidal effect by inhibiting the synthesis of bacterial cell wall. It has bactericidal effect on a wide range of common clinical bacteria and can resist hydrolysis by multiple beta-lactamases. Bacteria sensitive to this product include Gram-positive bacteria: Staphylococcus aureus (including strains that produce and do not produce penicillinase), Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus pyogenes, and Streptococcus agalactiae. Gram-negative bacteria: Escherichia coli, Klebsiella, Enterobacter, Citrobacter, Haemophilus influenzae (including strains that produce and do not produce beta-lactamase), Proteus mirabilis, Proteus vulgaris, Morganella morganii, Providencia, Serratia, Salmonella, Shigella. Pseudomonas aeruginosa and some other Pseudomonas, some strains of calcoacetic Acinetobacter. Neisseria gonorrhoeae (including strains that produce and do not produce penicillinase), Neisseria meningitidis, Bordetella pertussis. Anaerobic bacteria: Peptococcus, Peptostreptococcus, Veillonella, Clostridium, Eubacterium, Lactobacillus, Fusobacterium, various strains of Bacillus fragilis, and other Bacteroides.

More

It achieves bactericidal effect by inhibiting the synthesis of bacterial cell wall. It has bactericidal effect on a wide range of common clinical bacteria and can resist hydrolysis by multiple beta-lactamases. Bacteria sensitive to this product include Gram-positive bacteria: Staphylococcus aureus (including strains that produce and do not produce penicillinase), Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus pyogenes, and Streptococcus agalactiae. Gram-negative bacteria: Escherichia coli, Klebsiella, Enterobacter, Citrobacter, Haemophilus influenzae (including strains that produce and do not produce beta-lactamase), Proteus mirabilis, Proteus vulgaris, Morganella morganii, Providencia, Serratia, Salmonella, Shigella. Pseudomonas aeruginosa and some other Pseudomonas, some strains of calcoacetic Acinetobacter. Neisseria gonorrhoeae (including strains that produce and do not produce penicillinase), Neisseria meningitidis, Bordetella pertussis. Anaerobic bacteria: Peptococcus, Peptostreptococcus, Veillonella, Clostridium, Eubacterium, Lactobacillus, Fusobacterium, various strains of Bacillus fragilis, and other Bacteroides.

62893-20-3 23
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.